000 03325nam a22004575i 4500
001 60642
005 20200226102325.0
007 cr nn 008mamaa
008 170105s2017 si | s |||| 0|eng d
020 _a9789812878403
_9978-981-287-840-3
024 7 _a10.1007/978-981-287-840-3
_2doi
035 _a(DE-He213)978-981-287-840-3
050 4 _aRC681-688.2
072 7 _aMJD
_2bicssc
072 7 _aMED010000
_2bisacsh
082 0 4 _a616.12
_223
245 1 0 _aDiagnosis and Treatment of Pulmonary Hypertension
_h[electronic resource] :
_bFrom Bench to Bedside /
_cedited by Yoshihiro Fukumoto.
264 1 _aSingapore :
_bSpringer Singapore :
_bImprint: Springer,
_c2017.
300 _aVIII, 236 p. 70 illus., 45 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aPart I Fundamentals of Pulmonary Hypertension -- 1.Clinical Classification -- 2.Diagnosis – Imagings -- Part II Pathophysiology and Genetics -- 3.Pathogenic and Therapeutic Role of MicroRNA in Pulmonary Arterial Hypertension -- 4.Sex Hormones -- 5.Rho-Kinase -- 6.The Unique Property of the Pulmonary Artery Regard-ing the Smooth Muscle Effects of Proteinase-activated Receptor 1 - The Possible Contribution to the Pathogenesis of Pulmonary Hypertension -- 7. Animal Models with Pulmonary Hypertension -- 8.Human Pathology -- 9. Pathophysiology and Genetics: BMPR2 -- Part III Treatment of Pulmonary Arterial Hypertension (PAH) -- 10. Prostacyclin -- 11. Targeting the NO-sGC-cGMP pathway in pulmonary arterial hypertension -- 12. Endothelin Receptor Antagonist -- 13. LUNG TRANSPLANTATION -- Part IV Treatment of Chronic Thromboembolic Pulmonary Hypertension (CTEPH) -- 14. Medical Therapy for Chronic Thromboembolic Pulmonary Hypertension -- 15. Balloon Pulmonary Angioplasty -- 16. Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension -- Part V Right Ventricular Function -- 17. Right Ventricular Function.
520 _aThis book focuses on pulmonary arterial hypertension (PAH, Group 1) and chronic thromboembolic pulmonary hypertension (CTEPH, Group 4) among the various groups of pulmonary hypertension (PH) whose classification was updated into five major categories at the 5th World Symposium held in Nice, France, in 2013. Readers will find recent progress, methods, and up-to-date information on PH mechanisms, diagnostic images, and treatment in the management of PH. This volume, with contributions by leading researchers worldwide in the field , consists of five parts, starting with the fundamentals of PH, then pathophysiology and genetics, treatment, and right ventricular function.
650 0 _aMedicine.
650 0 _aCardiology.
650 0 _aRespiratory organs
_xDiseases.
650 0 _aCardiac surgery.
650 1 4 _aMedicine & Public Health.
650 2 4 _aCardiology.
650 2 4 _aPneumology/Respiratory System.
650 2 4 _aCardiac surgery.
700 1 _aFukumoto, Yoshihiro.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789812878397
856 4 0 _uhttp://dx.doi.org/10.1007/978-981-287-840-3
912 _aZDB-2-SME
999 _c1880
_d1880